Review



proteome profiler mouse cytokine array  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 98

    Structured Review

    R&D Systems proteome profiler mouse cytokine array
    Proteome Profiler Mouse Cytokine Array, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 807 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proteome profiler mouse cytokine array/product/R&D Systems
    Average 98 stars, based on 807 article reviews
    proteome profiler mouse cytokine array - by Bioz Stars, 2026-02
    98/100 stars

    Images



    Similar Products

    98
    R&D Systems proteome profiler mouse cytokine array
    Proteome Profiler Mouse Cytokine Array, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proteome profiler mouse cytokine array/product/R&D Systems
    Average 98 stars, based on 1 article reviews
    proteome profiler mouse cytokine array - by Bioz Stars, 2026-02
    98/100 stars
      Buy from Supplier

    97
    R&D Systems mouse cytokine array panel a
    Mouse Cytokine Array Panel A, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse cytokine array panel a/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    mouse cytokine array panel a - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    R&D Systems ary006
    Ary006, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ary006/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    ary006 - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    90
    R&D Systems Hematology proteome profiler mouse cytokine array kit, panel
    Proteome Profiler Mouse Cytokine Array Kit, Panel, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proteome profiler mouse cytokine array kit, panel/product/R&D Systems Hematology
    Average 90 stars, based on 1 article reviews
    proteome profiler mouse cytokine array kit, panel - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    97
    R&D Systems proteome profiler mouse cytokine array kit
    a , b WT (n = 5) and IFNAR1 −/− mice (n = 5) were immunized i.n . with NVT + H3N2. One day later, lung lysates and serum were collected. a Pooled lung lysates and serum samples were analyzed using a mouse <t>cytokine</t> kit. The signals were normalized to the pixel density of the indicated reference spots. b Concentrations of CCL2, CCL5, CXCL9, and CXCL10 in lung lysates and sera were measured via ELISA. c BALB/c Mice (n = 5 per group) were immunized i.n . with H3N2 or NVT. One day later, the levels of CCL2, CCL5, CXCL9, and CXCL10 in lung lysates and sera were assessed via ELISA. b , c Data are expressed as dot plots, with horizontal lines representing the medians. The two-sided Mann–Whitney U test was used for statistical analysis of differences between two groups. d , e BALB/c mice were immunized i . m . with H3N2 (n = 20), H3N2 + NVT (n = 10), or i . n . with H3N2 + NVT (n = 10) twice at two-week intervals. Two weeks later, mice injected i . m . with H3N2 (n = 10) or H3N2 + NVT (n = 10) were boosted i.n . with NVT. d On day 42, the proportion of lung CD4 + T RM cells from vaccinated mice (n = 5 per group) was determined via flow cytometry. e The other vaccinated mice (n = 5 per group) were infected i.n . with 4 LD 50 of H1N1 virus, and survival was monitored daily. Survival data are represented as Kaplan‒Meier survival curves, and the significant differences in survival rates were calculated by the log-rank test. f BALB/c mice were immunized i.n . with H3N2 + NVT (n = 15) or i.m . with H3N2 (n = 20). Two weeks later, the mice were immunized i.m . with H3N2 or i.n . with H3N2 + NVT, H3N2, or NVT, and the proportion of lung CD4 + T RM cells was determined via flow cytometry on day 42. d , f Box and whisker plots showing the median (center), 25th and 75th percentiles (box), and lowest and highest values (whiskers). Statistical analyses were performed using one-way ANOVA with the Tukey’s multiple comparisons test. This study was performed once. ns, not significant. Source data are provided as a Source Data file.
    Proteome Profiler Mouse Cytokine Array Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proteome profiler mouse cytokine array kit/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    proteome profiler mouse cytokine array kit - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    R&D Systems proteome profiler mouse cytokine array panel a
    a , b WT (n = 5) and IFNAR1 −/− mice (n = 5) were immunized i.n . with NVT + H3N2. One day later, lung lysates and serum were collected. a Pooled lung lysates and serum samples were analyzed using a mouse <t>cytokine</t> kit. The signals were normalized to the pixel density of the indicated reference spots. b Concentrations of CCL2, CCL5, CXCL9, and CXCL10 in lung lysates and sera were measured via ELISA. c BALB/c Mice (n = 5 per group) were immunized i.n . with H3N2 or NVT. One day later, the levels of CCL2, CCL5, CXCL9, and CXCL10 in lung lysates and sera were assessed via ELISA. b , c Data are expressed as dot plots, with horizontal lines representing the medians. The two-sided Mann–Whitney U test was used for statistical analysis of differences between two groups. d , e BALB/c mice were immunized i . m . with H3N2 (n = 20), H3N2 + NVT (n = 10), or i . n . with H3N2 + NVT (n = 10) twice at two-week intervals. Two weeks later, mice injected i . m . with H3N2 (n = 10) or H3N2 + NVT (n = 10) were boosted i.n . with NVT. d On day 42, the proportion of lung CD4 + T RM cells from vaccinated mice (n = 5 per group) was determined via flow cytometry. e The other vaccinated mice (n = 5 per group) were infected i.n . with 4 LD 50 of H1N1 virus, and survival was monitored daily. Survival data are represented as Kaplan‒Meier survival curves, and the significant differences in survival rates were calculated by the log-rank test. f BALB/c mice were immunized i.n . with H3N2 + NVT (n = 15) or i.m . with H3N2 (n = 20). Two weeks later, the mice were immunized i.m . with H3N2 or i.n . with H3N2 + NVT, H3N2, or NVT, and the proportion of lung CD4 + T RM cells was determined via flow cytometry on day 42. d , f Box and whisker plots showing the median (center), 25th and 75th percentiles (box), and lowest and highest values (whiskers). Statistical analyses were performed using one-way ANOVA with the Tukey’s multiple comparisons test. This study was performed once. ns, not significant. Source data are provided as a Source Data file.
    Proteome Profiler Mouse Cytokine Array Panel A, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proteome profiler mouse cytokine array panel a/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    proteome profiler mouse cytokine array panel a - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    R&D Systems protein profile array
    a , b WT (n = 5) and IFNAR1 −/− mice (n = 5) were immunized i.n . with NVT + H3N2. One day later, lung lysates and serum were collected. a Pooled lung lysates and serum samples were analyzed using a mouse <t>cytokine</t> kit. The signals were normalized to the pixel density of the indicated reference spots. b Concentrations of CCL2, CCL5, CXCL9, and CXCL10 in lung lysates and sera were measured via ELISA. c BALB/c Mice (n = 5 per group) were immunized i.n . with H3N2 or NVT. One day later, the levels of CCL2, CCL5, CXCL9, and CXCL10 in lung lysates and sera were assessed via ELISA. b , c Data are expressed as dot plots, with horizontal lines representing the medians. The two-sided Mann–Whitney U test was used for statistical analysis of differences between two groups. d , e BALB/c mice were immunized i . m . with H3N2 (n = 20), H3N2 + NVT (n = 10), or i . n . with H3N2 + NVT (n = 10) twice at two-week intervals. Two weeks later, mice injected i . m . with H3N2 (n = 10) or H3N2 + NVT (n = 10) were boosted i.n . with NVT. d On day 42, the proportion of lung CD4 + T RM cells from vaccinated mice (n = 5 per group) was determined via flow cytometry. e The other vaccinated mice (n = 5 per group) were infected i.n . with 4 LD 50 of H1N1 virus, and survival was monitored daily. Survival data are represented as Kaplan‒Meier survival curves, and the significant differences in survival rates were calculated by the log-rank test. f BALB/c mice were immunized i.n . with H3N2 + NVT (n = 15) or i.m . with H3N2 (n = 20). Two weeks later, the mice were immunized i.m . with H3N2 or i.n . with H3N2 + NVT, H3N2, or NVT, and the proportion of lung CD4 + T RM cells was determined via flow cytometry on day 42. d , f Box and whisker plots showing the median (center), 25th and 75th percentiles (box), and lowest and highest values (whiskers). Statistical analyses were performed using one-way ANOVA with the Tukey’s multiple comparisons test. This study was performed once. ns, not significant. Source data are provided as a Source Data file.
    Protein Profile Array, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/protein profile array/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    protein profile array - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    R&D Systems panel a
    a , b WT (n = 5) and IFNAR1 −/− mice (n = 5) were immunized i.n . with NVT + H3N2. One day later, lung lysates and serum were collected. a Pooled lung lysates and serum samples were analyzed using a mouse <t>cytokine</t> kit. The signals were normalized to the pixel density of the indicated reference spots. b Concentrations of CCL2, CCL5, CXCL9, and CXCL10 in lung lysates and sera were measured via ELISA. c BALB/c Mice (n = 5 per group) were immunized i.n . with H3N2 or NVT. One day later, the levels of CCL2, CCL5, CXCL9, and CXCL10 in lung lysates and sera were assessed via ELISA. b , c Data are expressed as dot plots, with horizontal lines representing the medians. The two-sided Mann–Whitney U test was used for statistical analysis of differences between two groups. d , e BALB/c mice were immunized i . m . with H3N2 (n = 20), H3N2 + NVT (n = 10), or i . n . with H3N2 + NVT (n = 10) twice at two-week intervals. Two weeks later, mice injected i . m . with H3N2 (n = 10) or H3N2 + NVT (n = 10) were boosted i.n . with NVT. d On day 42, the proportion of lung CD4 + T RM cells from vaccinated mice (n = 5 per group) was determined via flow cytometry. e The other vaccinated mice (n = 5 per group) were infected i.n . with 4 LD 50 of H1N1 virus, and survival was monitored daily. Survival data are represented as Kaplan‒Meier survival curves, and the significant differences in survival rates were calculated by the log-rank test. f BALB/c mice were immunized i.n . with H3N2 + NVT (n = 15) or i.m . with H3N2 (n = 20). Two weeks later, the mice were immunized i.m . with H3N2 or i.n . with H3N2 + NVT, H3N2, or NVT, and the proportion of lung CD4 + T RM cells was determined via flow cytometry on day 42. d , f Box and whisker plots showing the median (center), 25th and 75th percentiles (box), and lowest and highest values (whiskers). Statistical analyses were performed using one-way ANOVA with the Tukey’s multiple comparisons test. This study was performed once. ns, not significant. Source data are provided as a Source Data file.
    Panel A, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/panel a/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    panel a - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    Image Search Results


    a , b WT (n = 5) and IFNAR1 −/− mice (n = 5) were immunized i.n . with NVT + H3N2. One day later, lung lysates and serum were collected. a Pooled lung lysates and serum samples were analyzed using a mouse cytokine kit. The signals were normalized to the pixel density of the indicated reference spots. b Concentrations of CCL2, CCL5, CXCL9, and CXCL10 in lung lysates and sera were measured via ELISA. c BALB/c Mice (n = 5 per group) were immunized i.n . with H3N2 or NVT. One day later, the levels of CCL2, CCL5, CXCL9, and CXCL10 in lung lysates and sera were assessed via ELISA. b , c Data are expressed as dot plots, with horizontal lines representing the medians. The two-sided Mann–Whitney U test was used for statistical analysis of differences between two groups. d , e BALB/c mice were immunized i . m . with H3N2 (n = 20), H3N2 + NVT (n = 10), or i . n . with H3N2 + NVT (n = 10) twice at two-week intervals. Two weeks later, mice injected i . m . with H3N2 (n = 10) or H3N2 + NVT (n = 10) were boosted i.n . with NVT. d On day 42, the proportion of lung CD4 + T RM cells from vaccinated mice (n = 5 per group) was determined via flow cytometry. e The other vaccinated mice (n = 5 per group) were infected i.n . with 4 LD 50 of H1N1 virus, and survival was monitored daily. Survival data are represented as Kaplan‒Meier survival curves, and the significant differences in survival rates were calculated by the log-rank test. f BALB/c mice were immunized i.n . with H3N2 + NVT (n = 15) or i.m . with H3N2 (n = 20). Two weeks later, the mice were immunized i.m . with H3N2 or i.n . with H3N2 + NVT, H3N2, or NVT, and the proportion of lung CD4 + T RM cells was determined via flow cytometry on day 42. d , f Box and whisker plots showing the median (center), 25th and 75th percentiles (box), and lowest and highest values (whiskers). Statistical analyses were performed using one-way ANOVA with the Tukey’s multiple comparisons test. This study was performed once. ns, not significant. Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: A vaccine platform targeting lung-resident memory CD4 + T-cells provides protection against heterosubtypic influenza infections in mice and ferrets

    doi: 10.1038/s41467-024-54620-4

    Figure Lengend Snippet: a , b WT (n = 5) and IFNAR1 −/− mice (n = 5) were immunized i.n . with NVT + H3N2. One day later, lung lysates and serum were collected. a Pooled lung lysates and serum samples were analyzed using a mouse cytokine kit. The signals were normalized to the pixel density of the indicated reference spots. b Concentrations of CCL2, CCL5, CXCL9, and CXCL10 in lung lysates and sera were measured via ELISA. c BALB/c Mice (n = 5 per group) were immunized i.n . with H3N2 or NVT. One day later, the levels of CCL2, CCL5, CXCL9, and CXCL10 in lung lysates and sera were assessed via ELISA. b , c Data are expressed as dot plots, with horizontal lines representing the medians. The two-sided Mann–Whitney U test was used for statistical analysis of differences between two groups. d , e BALB/c mice were immunized i . m . with H3N2 (n = 20), H3N2 + NVT (n = 10), or i . n . with H3N2 + NVT (n = 10) twice at two-week intervals. Two weeks later, mice injected i . m . with H3N2 (n = 10) or H3N2 + NVT (n = 10) were boosted i.n . with NVT. d On day 42, the proportion of lung CD4 + T RM cells from vaccinated mice (n = 5 per group) was determined via flow cytometry. e The other vaccinated mice (n = 5 per group) were infected i.n . with 4 LD 50 of H1N1 virus, and survival was monitored daily. Survival data are represented as Kaplan‒Meier survival curves, and the significant differences in survival rates were calculated by the log-rank test. f BALB/c mice were immunized i.n . with H3N2 + NVT (n = 15) or i.m . with H3N2 (n = 20). Two weeks later, the mice were immunized i.m . with H3N2 or i.n . with H3N2 + NVT, H3N2, or NVT, and the proportion of lung CD4 + T RM cells was determined via flow cytometry on day 42. d , f Box and whisker plots showing the median (center), 25th and 75th percentiles (box), and lowest and highest values (whiskers). Statistical analyses were performed using one-way ANOVA with the Tukey’s multiple comparisons test. This study was performed once. ns, not significant. Source data are provided as a Source Data file.

    Article Snippet: Relative levels of cytokines and chemokines in lung lysates and serum from vaccinated mice were determined by a Proteome Profiler Mouse Cytokine Array Kit (Panel A, R&D Systems, Minneapolis, MN, USA) in accordance with the manufacturer’s recommendations.

    Techniques: Enzyme-linked Immunosorbent Assay, MANN-WHITNEY, Injection, Flow Cytometry, Infection, Virus, Whisker Assay